Cargando…
Addressing the selectivity and toxicity of antiviral nucleosides
Nucleoside and nucleotide analogs have played significant roles in antiviral therapies and are valued for their impressive potency and high barrier to resistance. They have been approved for treatment of herpes simplex virus-1, HIV, HBV, HCV, and influenza, and new drugs are being developed for the...
Autor principal: | Feng, Joy Y |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5890540/ https://www.ncbi.nlm.nih.gov/pubmed/29534607 http://dx.doi.org/10.1177/2040206618758524 |
Ejemplares similares
-
Antiviral nucleoside analogs
por: Kataev, Vladimir E., et al.
Publicado: (2021) -
Broad-Spectrum Antiviral Strategies and Nucleoside Analogues
por: Geraghty, Robert J., et al.
Publicado: (2021) -
Recent Advances in Molecular Mechanisms of Nucleoside Antivirals
por: Kamzeeva, Polina N., et al.
Publicado: (2023) -
Broad spectrum antiviral nucleosides—Our best hope for the future
por: Seley-Radtke, Katherine L., et al.
Publicado: (2021) -
Advanced Prodrug Strategies in Nucleoside and Non-Nucleoside Antiviral Agents: A Review of the Recent Five Years
por: Sinokrot, Hanadi, et al.
Publicado: (2017)